GLP-1 drugs , or glucagon-like peptide-1 compounds, represent a substantial innovation in how we treat type 2 diabetes . These new medications work by imitating the body’s natural GLP-1 process, which https://bookmarkingace.com/story21720250/glp-1-a-major-approach-in-diabetes-care